Current thinking and treatment practices in anaemia - An interactive poll

Medical Oncology

Volumn 17, Issue SUPPL. 1, 2000, Pages

  Spivak, J L ^a   Cazzola, M ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Anaemia; Cancer; Case studies; Recombinant human erythropoietin; Treatment practices

Indexed keywords

ERYTHROPOIETIN; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; CANCER; CANCER PATIENT; CLINICAL PRACTICE; CONFERENCE PAPER; DRUG RESPONSE; FEMALE; HEMATOCRIT; HEMOGLOBIN DETERMINATION; HUMAN; MALE; MEDICAL SPECIALIST; NORMAL HUMAN; PRIORITY JOURNAL; QUALITY OF LIFE; SYMPTOM; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT PLANNING; UNITED KINGDOM;

ANEMIA; ATTITUDE OF HEALTH PERSONNEL; ERYTHROPOIETIN; ERYTHROPOIETIN, RECOMBINANT; HEALTH CARE SURVEYS; HEMOGLOBINS; HUMANS; NEOPLASMS; PHYSICIAN'S PRACTICE PATTERNS; QUALITY OF LIFE;

EID: 0034533658     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (3)

1. Introduction: Suboptimal hemoglobin levels: Do they impact patients and their therapy?
2. Subcutaneous erythropoietin for treatment of refractory anemia in hematologic disorders. Results of a phase I/II clinical trial
3. Evaluation of erythroid marrow response to recombinant human erythropoietin in patients with cancer anaemia